Immunosuppressive therapy for active lymphocytic myocarditis: Virological and immunologic profile of responders versus nonresponders

Circulation

Volumn 107, Issue 6, 2003, Pages 857-863

  Frustaci, Andrea ^a   Chimenti, Cristina ^a   Calabrese, Fiorella ^b   Pieroni, Maurizio ^a   Thiene, Gaetano ^b   Maseri, Attilio ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Autoimmunity; Heart failure; Immunosuppression; Myocarditis; Viruses

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CARVEDILOL; DIGITALIS; ENALAPRIL; FUROSEMIDE; PREDNISONE;

ADENOVIRUS; ADOLESCENT; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; ENTEROVIRUS; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICULOGRAPHY; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENOME;

ADOLESCENT; ADULT; AUTOANTIBODIES; AZATHIOPRINE; BIOPSY; CARDIOTONIC AGENTS; CHRONIC DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; PREDNISONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TREATMENT OUTCOME;

EID: 0037448786     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000048147.15962.31     Document Type: Article

References (23)

1. Matitiau A, Perez-Atayde A, Sanders SP, et al. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation. 1994;90:1310-1318.
2. Lee KJ, McCrindle BW, Bohn DJ, et al. Clinical outcomes of acute myocarditis in childhood. Heart. 1999;82:226-233.
3. Parrillo JE, Cunnion RE, Epstein SE, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med. 1989;321:1061-1068.
4. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis: the Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333:269-275.
5. Chimenti C, Calabrese F, Thiene G, et al. Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias. Circulation. 2001;104:168-173.
6. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343:1388-1398.
7. Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985;312:885-890.
8. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation. 2001;104:39-45.
9. Aretz H, Billingham ME, Edwards WD, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol. 1986;1:3-14.
10. Calabrese F, Valente ML, Thiene G, et al. Enteroviral genome in native heart may influence outcome of patients who undergo cardiac transplantation. Diagn Mol Pathol. 1999;8:39-46.
11. Caforio AL, Bonifacio E, Stewart JT, et al. Novel organ-specific auto-antibodies in dilated cardiomyopathy. J Am Coil Cardiol. 1990;15:1527-1534.
12. Frustaci A, Gentiloni N, Chimenti C, et al. Necrotizing myocardial vasculitis in Churg-Strauss syndrome: clinico-histologic evaluation of steroids and immunosuppressive therapy. Chest. 1998;114:1484-1489.
13. Tomioka N, Kishimoto C, Matsumori A, et al. Effects of prednisolone on acute viral myocarditis in mice. J Am Coll Cardiol. 1986;7:868-872.
14. Rose NR. Viral damage or molecular mimicry-placing the blame in myocarditis. Naz Med. 2000;6:631-632.
15. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001;104:1076-1082.
16. Kishimoto C, Thorp KA, Abelmann WH. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine coxsackievirus B3 myocarditis. Circulation. 1990;82:982-989.
17. Shirali GS, Ni J, Chinnock RE, et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med. 2001;344:1498-1503.
18. Kuhl U, Pauschinger M, Schwimmbeck PL, et al. Interferon-β treatment of patients with enteroviral and adenoviral cardiomyopathy causes effective virus clearance and long-term clinical improvement. Circulation. 2001;104(Suppl):3220. Abstract.
19. Durand JM, Lefevre P, Harle JR, et al. Cutaneous vasculitis and cryoglobulinaemia type 2 associated with hepatitis C infection. Lancet. 1991;337:499-500.
20. Johnson RJ, Gretch DR, Yarnabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328:465-470.
21. Okabe M, Fukuda K, Arakawa K, et al. Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation. 1997;96:22-24.
22. Vento S, Cainelli F, Longhi MS. Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue. Lancet Oncol. 2002;3:333-340.
23. Martin AB, Webber S, Fricker FJ, et al. Acute myocarditis: rapid diagnosis by PCR in children. Circulation. 1994;90:330-339.